September 1, 200719 yr by The Associated Press Posted: August 31, 2007 - 5:00 pm ET (Washington) A new HIV-fighting drug from Merck & Co. appears superior to options for patients who have stopped responding to available drugs, federal regulators said Friday. The Food and Drug Administration said Merck's studies of Isentress show the drug is safe and effective to treat HIV patients who have developed a resistance to other medications. Roughly 1 million people in the U.S. are HIV positive, according to the Centers for Disease Control. FDA has cleared 30 different HIV treatments since 1987, and they are typically prescribed in combination to suppress the virus, which cripples the immune system and causes death if not treated. Read the full story at: http://365gay.com/Newscon07/08/083107med.htm
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.